Pantoprazole Amarox (Pantoprazole)

Pantoprazole Amarox is a proton pump inhibitor indicated for several acid‑related gastrointestinal conditions:

• Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of the esophageal lining.
• Erosive esophagitis: accelerates mucosal healing and reduces further acid injury.
• Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumors.
• NSAID‑induced gastric ulcer: aids ulcer healing and prevents recurrence.

• Pantoprazole selectively inhibits the H+/K+ ATPase enzyme (gastric proton pump) located on the secretory surface of gastric parietal cells. By binding to this pump, it blocks the final step of acid production, leading to a sustained reduction in gastric acidity and allowing the gastrointestinal mucosa to heal.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually self‑limiting.
• Nausea: occasional and transient.
• Abdominal pain: mild discomfort.
• Flatulence: excess gas.
• Constipation: infrequent.

Serious or Rare Side Effects

• Severe allergic reaction: rash, itching, swelling, dizziness, trouble breathing.
• Clostridioides difficile infection: persistent watery diarrhea.
• Low magnesium levels: muscle cramps, irregular heartbeat.
• Fracture risk: especially with long‑term use.
• Vitamin B12 deficiency: anemia, neuropathy.
• Acute interstitial nephritis: kidney inflammation.

Before prescribing Pantoprazole Amarox, consider the following precautions:

• Assess renal function: dose adjustment may be needed in severe impairment.
• Review liver disease: monitor for accumulation in hepatic impairment.
• Evaluate long‑term use: assess fracture risk and bone health.
• Monitor electrolytes: watch for hypomagnesemia with prolonged therapy.
• Pregnancy and lactation: use only if clearly needed.
• Store at ambient temperature: keep in original packaging, protect from moisture.

Pantoprazole may interact with several medications; monitoring is advised.

Major Interactions (Avoid)

• Ketoconazole oral suspension: reduced absorption due to higher gastric pH.
• Atazanavir: decreased plasma concentrations, risking antiviral failure.
• Clopidogrel: diminished antiplatelet effect, increasing cardiovascular risk.

Moderate Interactions (Monitor Closely)

• Warfarin: potential increase in INR values.
• Methotrexate: elevated serum levels, especially in renal impairment.
• Digoxin: slight increase in serum concentration.
• Iron supplements: decreased absorption, separate dosing by 2‑hours.
• Mycophenolate mofetil: reduced exposure, consider alternative timing.